Matches in SemOpenAlex for { <https://semopenalex.org/work/W4367301410> ?p ?o ?g. }
- W4367301410 abstract "Natural products are ligands and potential inhibitors of Alzheimer's disease (AD) tau. Dihydromyricetin (DHM) is a CNS active natural product. Despite having signature polyphenolic character, DHM is ostensibly hydrophobic owing to intermolecular hydrogen bonds that shield hydrophilic phenols. Our research shows DHM becomes ionized at near-neutral pH allowing formulation of salts with transformed solubility. The MicroED co-crystal structure with trolamine reveals DHM salts as metastable solids with unlocked hydrogen bonding and a thermodynamic bent to solubilize in water. All salt formulations show better inhibitory activity against AD tau than the non-salt form, with efficacies correlating to enhanced solubilities. These results underscore the role of structural chemistry in guiding selection of solubilizing agents for chemical formulation. We propose DHM salts are appropriate formulations for research as dietary supplements to promote healthy aging by combating protein misfolding. Additionally, DHM is a suitable lead for medicinal chemistry and possible development of CNS pharmaceuticals." @default.
- W4367301410 created "2023-04-29" @default.
- W4367301410 creator A5002294079 @default.
- W4367301410 creator A5005908795 @default.
- W4367301410 creator A5010612179 @default.
- W4367301410 creator A5016253604 @default.
- W4367301410 creator A5025017344 @default.
- W4367301410 creator A5027198967 @default.
- W4367301410 creator A5038419656 @default.
- W4367301410 creator A5038796731 @default.
- W4367301410 creator A5040650353 @default.
- W4367301410 creator A5045355029 @default.
- W4367301410 creator A5052194265 @default.
- W4367301410 creator A5061526689 @default.
- W4367301410 creator A5070956637 @default.
- W4367301410 creator A5084200031 @default.
- W4367301410 date "2023-04-28" @default.
- W4367301410 modified "2023-09-29" @default.
- W4367301410 title "Improving the solubility of pseudo-hydrophobic Alzheimer's Disease medicinal chemicals through co-crystal formulation" @default.
- W4367301410 cites W1498305210 @default.
- W4367301410 cites W1969360633 @default.
- W4367301410 cites W2001454290 @default.
- W4367301410 cites W2002609875 @default.
- W4367301410 cites W2014694459 @default.
- W4367301410 cites W2027714953 @default.
- W4367301410 cites W2081550487 @default.
- W4367301410 cites W2108243628 @default.
- W4367301410 cites W2132454074 @default.
- W4367301410 cites W2133061394 @default.
- W4367301410 cites W2147874841 @default.
- W4367301410 cites W2151823004 @default.
- W4367301410 cites W2160108669 @default.
- W4367301410 cites W2565481405 @default.
- W4367301410 cites W2798114001 @default.
- W4367301410 cites W2806393666 @default.
- W4367301410 cites W2899058127 @default.
- W4367301410 cites W2936758967 @default.
- W4367301410 cites W2967960051 @default.
- W4367301410 cites W2973289353 @default.
- W4367301410 cites W3014436063 @default.
- W4367301410 cites W3041208611 @default.
- W4367301410 cites W3073477711 @default.
- W4367301410 cites W3093436856 @default.
- W4367301410 cites W3136753702 @default.
- W4367301410 cites W3138859876 @default.
- W4367301410 cites W3179773172 @default.
- W4367301410 cites W3196964953 @default.
- W4367301410 cites W4200339870 @default.
- W4367301410 cites W4225272260 @default.
- W4367301410 cites W4248872320 @default.
- W4367301410 cites W4296160966 @default.
- W4367301410 cites W4308148123 @default.
- W4367301410 cites W636035323 @default.
- W4367301410 doi "https://doi.org/10.1101/2023.04.25.538327" @default.
- W4367301410 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37162961" @default.
- W4367301410 hasPublicationYear "2023" @default.
- W4367301410 type Work @default.
- W4367301410 citedByCount "0" @default.
- W4367301410 crossrefType "posted-content" @default.
- W4367301410 hasAuthorship W4367301410A5002294079 @default.
- W4367301410 hasAuthorship W4367301410A5005908795 @default.
- W4367301410 hasAuthorship W4367301410A5010612179 @default.
- W4367301410 hasAuthorship W4367301410A5016253604 @default.
- W4367301410 hasAuthorship W4367301410A5025017344 @default.
- W4367301410 hasAuthorship W4367301410A5027198967 @default.
- W4367301410 hasAuthorship W4367301410A5038419656 @default.
- W4367301410 hasAuthorship W4367301410A5038796731 @default.
- W4367301410 hasAuthorship W4367301410A5040650353 @default.
- W4367301410 hasAuthorship W4367301410A5045355029 @default.
- W4367301410 hasAuthorship W4367301410A5052194265 @default.
- W4367301410 hasAuthorship W4367301410A5061526689 @default.
- W4367301410 hasAuthorship W4367301410A5070956637 @default.
- W4367301410 hasAuthorship W4367301410A5084200031 @default.
- W4367301410 hasBestOaLocation W43673014101 @default.
- W4367301410 hasConcept C104317684 @default.
- W4367301410 hasConcept C112887158 @default.
- W4367301410 hasConcept C143065580 @default.
- W4367301410 hasConcept C155574463 @default.
- W4367301410 hasConcept C166950319 @default.
- W4367301410 hasConcept C178790620 @default.
- W4367301410 hasConcept C185592680 @default.
- W4367301410 hasConcept C199360897 @default.
- W4367301410 hasConcept C21951064 @default.
- W4367301410 hasConcept C2776371256 @default.
- W4367301410 hasConcept C2778004101 @default.
- W4367301410 hasConcept C2781285689 @default.
- W4367301410 hasConcept C30765947 @default.
- W4367301410 hasConcept C32909587 @default.
- W4367301410 hasConcept C41008148 @default.
- W4367301410 hasConcept C55493867 @default.
- W4367301410 hasConcept C70899900 @default.
- W4367301410 hasConcept C90260826 @default.
- W4367301410 hasConceptScore W4367301410C104317684 @default.
- W4367301410 hasConceptScore W4367301410C112887158 @default.
- W4367301410 hasConceptScore W4367301410C143065580 @default.
- W4367301410 hasConceptScore W4367301410C155574463 @default.
- W4367301410 hasConceptScore W4367301410C166950319 @default.
- W4367301410 hasConceptScore W4367301410C178790620 @default.
- W4367301410 hasConceptScore W4367301410C185592680 @default.
- W4367301410 hasConceptScore W4367301410C199360897 @default.